BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1240 related articles for article (PubMed ID: 11011852)

  • 21. Effects of multivitamins and low-dose folic acid supplements on flow-mediated vasodilation and plasma homocysteine levels in older adults.
    Carlsson CM; Pharo LM; Aeschlimann SE; Mitchell C; Underbakke G; Stein JH
    Am Heart J; 2004 Sep; 148(3):E11. PubMed ID: 15389247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mild hyperhomocysteinemia is an independent risk factor of arterial vascular disease.
    Boers GH
    Semin Thromb Hemost; 2000; 26(3):291-5. PubMed ID: 11011846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of multivitamin supplementation on the homocysteine and methylmalonic acid blood concentrations in women over the age of 60 years.
    Wolters M; Hermann S; Hahn A
    Eur J Nutr; 2005 Mar; 44(3):183-92. PubMed ID: 15309436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated plasma homocysteine and low vitamin B-6 status in nonsupplementing older women with rheumatoid arthritis.
    Woolf K; Manore MM
    J Am Diet Assoc; 2008 Mar; 108(3):443-53; discussion 454. PubMed ID: 18313425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Folate, vitamin B12 and homocysteine status in women of childbearing age: baseline data of folic acid wheat flour fortification in Iran.
    Abdollahi Z; Elmadfa I; Djazayeri A; Sadeghian S; Freisling H; Mazandarani FS; Mohamed K
    Ann Nutr Metab; 2008; 53(2):143-50. PubMed ID: 18997463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Group B vitamins as new variables related to the cardiovascular risk].
    Granieri M; Bellisarii FI; De Caterina R
    Ital Heart J Suppl; 2005 Jan; 6(1):1-16. PubMed ID: 15776726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral vitamin B12 supplementation reduces plasma total homocysteine concentration in women in India.
    Yajnik CS; Lubree HG; Thuse NV; Ramdas LV; Deshpande SS; Deshpande VU; Deshpande JA; Uradey BS; Ganpule AA; Naik SS; Joshi NP; Farrant H; Refsum H
    Asia Pac J Clin Nutr; 2007; 16(1):103-9. PubMed ID: 17215186
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Homocysteine lowering and cardiovascular events after acute myocardial infarction.
    Bønaa KH; Njølstad I; Ueland PM; Schirmer H; Tverdal A; Steigen T; Wang H; Nordrehaug JE; Arnesen E; Rasmussen K;
    N Engl J Med; 2006 Apr; 354(15):1578-88. PubMed ID: 16531614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Efficacy and safety of two vitamin supplement regimens on homocysteine levels in hemodialysis patients. Prospective, randomized clinical trial].
    Sánchez Alvarez JE; Pérez Tamajón L; Hernández D; Alvarez González A; Delgado P; Lorenzo V
    Nefrologia; 2005; 25(3):288-96. PubMed ID: 16053010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Homocysteine-lowering trials for prevention of heart disease and stroke.
    Clarke R
    Semin Vasc Med; 2005 May; 5(2):215-22. PubMed ID: 16047274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vitamin B12 and folic acid supplementation and plasma total homocysteine concentrations in pregnant Indian women with low B12 and high folate status.
    Katre P; Bhat D; Lubree H; Otiv S; Joshi S; Joglekar C; Rush E; Yajnik C
    Asia Pac J Clin Nutr; 2010; 19(3):335-43. PubMed ID: 20805077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperhomocysteinemia: clinical and therapeutical involvement in venous thrombosis.
    Hoţoleanu C; Porojan-Iuga M; Rusu ML; Andercou A
    Rom J Intern Med; 2007; 45(2):159-64. PubMed ID: 18333369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uremic hyperhomocysteinemia: a randomized trial of folate treatment for the prevention of cardiovascular events.
    Vianna AC; Mocelin AJ; Matsuo T; Morais-Filho D; Largura A; Delfino VA; Soares AE; Matni AM
    Hemodial Int; 2007 Apr; 11(2):210-6. PubMed ID: 17403173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Folic acid and vitamin B12 are more effective than vitamin B6 in lowering fasting plasma homocysteine concentration in patients with coronary artery disease.
    Lee BJ; Huang MC; Chung LJ; Cheng CH; Lin KL; Su KH; Huang YC
    Eur J Clin Nutr; 2004 Mar; 58(3):481-7. PubMed ID: 14985687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M;
    Clin Chem Lab Med; 2003 Nov; 41(11):1392-403. PubMed ID: 14656016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. No effect of homocysteine-lowering therapy on vascular inflammation and haemostasis in peripheral arterial occlusive disease.
    Schernthaner GH; Plank C; Minar E; Bieglmayer C; Koppensteiner R; Schernthaner G
    Eur J Clin Invest; 2006 May; 36(5):333-9. PubMed ID: 16634837
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased rate of coronary restenosis after lowering of plasma homocysteine levels.
    Schnyder G; Roffi M; Pin R; Flammer Y; Lange H; Eberli FR; Meier B; Turi ZG; Hess OM
    N Engl J Med; 2001 Nov; 345(22):1593-600. PubMed ID: 11757505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Meta-analysis of folic acid supplementation trials on risk of cardiovascular disease and risk interaction with baseline homocysteine levels.
    Miller ER; Juraschek S; Pastor-Barriuso R; Bazzano LA; Appel LJ; Guallar E
    Am J Cardiol; 2010 Aug; 106(4):517-27. PubMed ID: 20691310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial.
    Toole JF; Malinow MR; Chambless LE; Spence JD; Pettigrew LC; Howard VJ; Sides EG; Wang CH; Stampfer M
    JAMA; 2004 Feb; 291(5):565-75. PubMed ID: 14762035
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Vitamin treatments that lower homocysteine concentration: can they decrease cerebrovascular disease in primary prevention?].
    Méndez-González J; Rodríguez-Millán E; Julve J; Blanco-Vaca F
    Rev Neurol; 2010 Feb 16-28; 50(4):235-44. PubMed ID: 20198596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 62.